STAT6 activation confers upon T helper cells resistance to suppression by regulatory T cells

Journal of Immunology

Volumn 183, Issue 1, 2009, Pages 155-163

  Pillemer, Brendan B L ^a   Qi, Zengbiao ^a   Melgert, Barbro ^b   Oriss, Timothy B ^a   Ray, Prabir ^a,c   Ray, Anuradha ^a,c  

^a Division of Pulmonary Allergy and Critical Care Medicine   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA; STAT6 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; AUTACOID; STAT6 PROTEIN, MOUSE;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ALLERGIC DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; TH2 CELL; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; COMPARATIVE STUDY; DISEASE MODEL; GENE TARGETING; GENETICS; HELPER CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; LUNG; METABOLISM; PATHOLOGY; PHYSIOLOGY; RESPIRATORY TRACT ALLERGY;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GENE KNOCK-IN TECHNIQUES; IMMUNE TOLERANCE; IMMUNITY, INNATE; IMMUNOSUPPRESSION; INFLAMMATION MEDIATORS; INTERLEUKIN-4; LUNG; MALE; MICE; MICE, INBRED BALB C; RESPIRATORY HYPERSENSITIVITY; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY;

EID: 68949103932     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803733     Document Type: Article

References (53)

1. Thomson, A. W. 2003. The Cytokine Handbook. Academic Press, San Diego, CA.
2. Abramson, M. J., R. M. Puy, and J. M. Weiner. 2003. Allergen immunotherapy for asthma. Cochrane Database Syst. Rev. CD001186.
3. Janeway, C. 2005. Immunobiology: The Immune System in Health and Disease. Garland Science, New York.
4. Paul, W. E. 2003. Fundamental Immunology. Lippincott Williams & Wilkins, Philadelphia.
5. Kaplan, M. H., U. Schindler, S. T. Smiley, and M. J. Grusby. 1996. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4: 313-319.
6. Shimoda, K., J. van Deursen, M. Y. Sangster, S. R. Sarawar, R. T. Carson, R. A. Tripp, C. Chu, F. W. Quelle, T. Nosaka, D. A. Vignali, et al. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380: 630-633.
7. Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S. Kashiwamura, K. Nakanishi, N. Yoshida, T. Kishimoto, and S. Akira. 1996. Essential role of Stat6 in IL-4 signalling. Nature 380: 627-630.
8. + T cell IL-4 production is revealed in IL-4 receptor-deficient mice. Proc. Natl. Acad. Sci. USA 94: 10838-10843.
9. Kruse, S., T. Japha, M. Tedner, S. H. Sparholt, J. Forster, J. Kuehr, and K. A. Deichmann. 1999. The polymorphisms S503P and Q576R in the interleukin-4 receptor α gene are associated with atopy and influence the signal transduction. Immunology 96: 365-371.
10. Hershey, G. K., M. F. Friedrich, L. A. Esswein, M. L. Thomas, and T. A. Chatila. 1997. The association of atopy with a gain-of-function mutation in the α subunit of the interleukin-4 receptor. N. Engl. J. Med. 337: 1720-1725.
11. + T cells expressing membrane-bound TGF-β and FOXP3. J. Clin. Invest. 114: 28-38.
12. + influx, and NFATc translocation causing inhibition of T cell differentiation. J. Exp. Med. 197: 1689-1699.
13. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194: 629-644.
14. high T cells in human STAT5b deficiency. J. Immunol. 177: 2770-2774.
15. + T cell suppressor function. J. Immunol. 172: 6519-6523.
16. + T cell suppressor function. Eur. J. Immunol. 34: 366-376.
17. - cells to develop suppressive activity: the role of IL-2. TGF-β, and IL-10. J. Immunol. 172: 5213-5221.
18. + regulatory T cells. J. Immunol. 172: 5287-5296.
19. + regulatory T cells and for expansion of these cells. J. Immunol. 178: 2018-2027.
20. Ostroukhova, M., Z. Qi, T. B. Oriss, B. Dixon-McCarthy, P. Ray, and A. Ray. 2006. Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-β. J. Clin. Invest. 116: 996-1004.
21. + regulatory T cells and SOCS3-mediated suppression of Treg function. Eur. J. Immunol. 37: 2082-2089.
22. Zhang, D. H., L. Cohn, P. Ray, K. Bottomly, and A. Ray. 1997. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J. Biol. Chem. 272: 21597-21603.
23. Zhu, J., L. Guo, C. J. Watson, J. Hu-Li, and W. E. Paul. 2001. Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion. J. Immunol. 166: 7276-7281. (Pubitemid 32525602)
24. + FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-β dependent but does not confer a regulatory phenotype. Blood 110: 2983-2990.
25. Miyara, M., and S. Sakaguchi. 2007. Natural regulatory T cells: mechanisms of suppression. Trends Mol. Med. 13: 108-116.
26. Vignali, D. A., L. W. Collison, and C. J. Workman. 2008. How regulatory T cells work. Nat. Rev. 8: 523-532.
27. + T cells from the target organ of patients with rheumatoid arthritis. Eur. J. Immunol. 33: 215-223.
28. Marshall, N. A., L. E. Christie, L. R. Munro, D. J. Culligan, P. W. Johnston, R. N. Barker, and M. A. Vickers. 2004. Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood 103: 1755-1762.
29. Miyara, M., Z. Amoura, C. Parizot, C. Badoual, K. Dorgham, S. Trad, M. Kambouchner, D. Valeyre, C. Chapelon-Abric, P. Debre, et al. 2006. The immune paradox of sarcoidosis and regulatory T cells. J. Exp. Med. 203: 359-370.
30. Taylor, J. J., M. Mohrs, and E. J. Pearce. 2006. Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the Th effector population. J. Immunol. 176: 5839-5847.
31. + T lymphocytes and relation to hepatic inflammation during chronic HCV infection. J. Hepatol. 47: 316-324.
32. Korn, T., J. Reddy, W. Gao, E. Bettelli, A. Awasthi, T. R. Petersen, B. T. Backstrom, R. A. Sobel, K. W. Wucherpfennig, T. B. Strom, et al. 2007. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13: 423-431.
33. + regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 29: 114-126.
34. + T regulatory cells. J. Immunol. 177: 5115-5121.
35. + regulatory T cells. Front. Biosci. 13: 1440-1446.
36. high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients. Blood 108: 2655-2661.
37. Takaki, H., K. Ichiyama, K. Koga, T. Chinen, G. Takaesu, Y. Sugiyama, S. Kato, A. Yoshimura, and T. Kobayashi. 2008. STAT6 Inhibits TGF-β1-mediated Foxp3 induction through direct binding to the Foxp3 promoter, which is reverted by retinoic acid receptor. J. Biol. Chem. 283: 14955-14962.
38. + T regulatory cell-mediated suppression. J. Immunol. 174: 7645-7653.
39. + regulatory T cell-mediated suppression. J. Immunol. 176: 3900-3904.
40. Sun, X. J., L. M. Wang, Y. Zhang, L. Yenush, M. G. Myers, Jr., E. Glasheen, W. S. Lane, J. H. Pierce, and M. F. White. 1995. Role of IRS-2 in insulin and cytokine signalling. Nature 377: 173-177.
41. Vella, A., T. K. Teague, J. Ihle, J. Kappler, and P. Marrack. 1997. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: Stat6 is probably not required for the effect of IL-4. J. Exp. Med. 186: 325-330.
42. Zamorano, J., H. Y. Wang, L. M. Wang, J. H. Pierce, and A. D. Keegan. 1996. IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway. J. Immunol. 157: 4926-4934.
43. Daniel, C., A. Salvekar, and U. Schindler. 2000. A gain-of-function mutation in STAT6. J. Biol. Chem. 275: 14255-14259.
44. Lee, D. U., and A. Rao. 2004. Molecular analysis of a locus control region in the T helper cytokine gene cluster: a target for STAT6 but not GATA3. Proc. Natl. Acad. Sci. USA 101: 16010-16015.
45. Fontenot, J. D., J. P. Rasmussen, M. A. Gavin, and A. Y. Rudensky. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6: 1142-1151.
46. + regulatory T cells. Nat. Immunol. 9: 632-640.
47. Zhang, D. H., L. Yang, L. Cohn, L. Parkyn, R. Homer, P. Ray, and A. Ray. 1999. Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3. Immunity. 11: 473-482.
48. Zheng, W., and R. A. Flavell. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89: 587-596. (Pubitemid 27511769)
49. Mohrs, M., D. A. Lacy, and R. M. Locksley. 2003. Stat signals release activated naive Th cells from an anergic checkpoint. J. Immunol. 170: 1870-1876.
50. + regulatory T cells confer infectious tolerance in a TGF-β-dependent manner. J. Exp. Med. 205: 1975-1981.
51. Mantel, P. Y., H. Kuipers, O. Boyman, C. Rhyner, N. Ouaked, B. Ruckert, C. Karagiannidis, B. N. Lambrecht, R. W. Hendriks, R. Crameri et al. 2007. GATA3-driven Th2 responses inhibit TGF-β1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol. 5: e329.
52. Wenzel, S., D. Wilbraham, R. Fuller, E. B. Getz, and M. Longphre. 2007. Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. Lancet 370: 1422-1431.
53. Kubo, T., R. D. Hatton, J. Oliver, X. Liu, C. O. Elson, and C. T. Weaver. 2004. Regulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLR-activated dendritic cells. J. Immunol. 173: 7249-7258.